NEUTRON HOLDINGS INC (LIME)

NASDAQInformation TechnologyRental & Leasing ServicesSnapshot 2026-10-23

$26.19-2.39%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge NEUTRON HOLDINGS INC’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-31
Revenue	—	244.8M
EPS	—	0.02
Annual ending 2026-12-31
Revenue	—	1.07B
EPS	—	4.085
Annual ending 2027-12-31
Revenue	—	1.23B
EPS	—	1.433

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Disciplined capital allocation with credit facility and buybacks	The company aims for disciplined capital allocation with a new $200 million credit facility.	Intact	fails to maintain the $200 million credit facility	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Newly stated in 2026-Q2. Management announced a $200 million senior secured revolving credit facility and a share buyback program in July 2026. Financials for 2026-Q2 show revenue of $304.2 million and operating income of $12.8 million. This priority is newly introduced and the trajectory is to be determined. Delivery assessment Oct 24, 2026
Prudent debt management and financial obligations	A supporting condition in NEUTRON HOLDINGS INC's published investment case. The stated target is repay $115 million senior secured term loan facility.	Recovered	fails to repay the $115 million term loan	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Newly stated in 2026-Q2. Management repaid the $115 million senior secured term loan facility in full using IPO proceeds. This action demonstrates prudent debt management, with the trajectory currently aligned with strengthening the balance sheet. Delivery assessment Oct 24, 2026
Revenue growth and profitability improvement	A primary condition in NEUTRON HOLDINGS INC's published investment case. The stated target is >=15% YoY.	Intact	falls below 15% YoY revenue growth next year	Required source inputs unavailable Cannot calculate Revenue growth from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Newly stated in 2026-Q2. The company reported revenue of $304.2 million and operating income of $12.8 million in 2026-Q2. This financial performance reflects the current focus on growth and profitability, with trajectory to be assessed in future quarters. Delivery assessment Oct 24, 2026

Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · alphavantage

FY2027 EPS: comparable history unavailable.

FY2027 revenue$1.23B

$1.23B → $1.23B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · alphavantage
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-10-19	Unavailable	$1,230,072,730	3 / 8
2026-10-20	Unavailable	$1,230,072,730	3 / 8
2026-10-21	Unavailable	$1,230,072,730	3 / 8
2026-10-22	Unavailable	$1,230,072,730	3 / 8
2026-10-23	Unavailable	$1,230,072,730	3 / 8
2026-10-24	Unavailable	$1,230,072,730	3 / 8

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-07-01	8	0	0
2026-08-01	8	0	0
2026-09-01	8	0	0
2026-10-01	8	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 8 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Disciplined capital allocation with credit facility and buybacksDirect metric needs a verified mapping
Prudent debt management and financial obligationsDirect metric needs a verified mapping
Revenue growth and profitability improvementRequired source inputs unavailable

Next proof point

Nov 3, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.7%Typical daily move · historical

Downside history

-43.7%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

NEUTRON HOLDINGS INC outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

LIME is an early-stage, higher-risk business thesis rather than an established durable compounder. The current thesis state is insufficient because there is not enough recent financial history to assess performance over time.

What's priced into NEUTRON HOLDINGS INC

The snapshot provides no valuation or expectations data, so it is not possible to judge whether LIME is cheap, fair, or expensive versus peers, or what the market already assumes. The priced-in fragility assessment is low, but that does not establish the valuation.

What the fundamentals likely do

In the near term, management has stated priorities around growth, profitability, capital allocation, and debt management, but their trajectories remain to be assessed. The latest cited quarter had revenue of $304.2 million and operating income of $12.8 million; LIME also repaid its $115 million term loan with IPO proceeds and announced a credit facility and share buyback. Risk remains elevated, and the evidence is too limited to establish a multi-year operating trend.

What NEUTRON HOLDINGS INC hinges on

The multi-year view hinges on whether LIME can turn its new priorities into sustained revenue growth and profitability while managing financial obligations prudently. Near-term sector conditions could help or hurt: Fed rate cuts and continued strength from major Tech companies would be tailwinds, while weaker results or guidance from those companies could remove that support.

Bottom line

LIME’s 1-3 year thesis remains uncertain because operating history and valuation evidence are thin, while execution and sector conditions are meaningful swing factors. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.